HEADER PROTEIN BINDING 05-MAY-15 4ZO1 TITLE CRYSTAL STRUCTURE OF THE T3-BOUND TR-BETA LIGAND-BINDING DOMAIN IN TITLE 2 COMPLEX WITH RXR-ALPHA COMPND MOL_ID: 1; COMPND 2 MOLECULE: THYROID HORMONE RECEPTOR BETA; COMPND 3 CHAIN: X; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN UNP RESIDUES 210-461; COMPND 5 SYNONYM: NUCLEAR RECEPTOR SUBFAMILY 1 GROUP A MEMBER 2,C-ERBA-2,C- COMPND 6 ERBA-BETA; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: NUCLEAR RECEPTOR COACTIVATOR 2; COMPND 10 CHAIN: A; COMPND 11 SYNONYM: NCOA-2,CLASS E BASIC HELIX-LOOP-HELIX PROTEIN 75,BHLHE75, COMPND 12 TRANSCRIPTIONAL INTERMEDIARY FACTOR 2,HTIF2; COMPND 13 ENGINEERED: YES; COMPND 14 MOL_ID: 3; COMPND 15 MOLECULE: RETINOIC ACID RECEPTOR RXR-ALPHA; COMPND 16 CHAIN: B; COMPND 17 FRAGMENT: LIGAND BINDING DOMAIN, UNP RESIDUES 231-455; COMPND 18 SYNONYM: NUCLEAR RECEPTOR SUBFAMILY 2 GROUP B MEMBER 1,RETINOID X COMPND 19 RECEPTOR ALPHA SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: THRB, ERBA2, NR1A2, THR1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 MOL_ID: 2; SOURCE 11 SYNTHETIC: YES; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 OTHER_DETAILS: THIS SEQUENCE OCCURS NATURALLY IN HUMANS; SOURCE 16 MOL_ID: 3; SOURCE 17 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 18 ORGANISM_COMMON: HUMAN; SOURCE 19 ORGANISM_TAXID: 9606 KEYWDS NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- KEYWDS 2 LIGAND COMPLEX, PROTEIN BINDING EXPDTA X-RAY DIFFRACTION AUTHOR J.B.BRUNING,D.J.KOJETIN,E.MATTA-CAMACHO,T.S.HUGHES,S.SRINIVASAN, AUTHOR 2 J.C.NWACHUKWU,V.CAVETT,J.NOWAK,M.J.CHALMERS,D.P.MARCIANO, AUTHOR 3 T.M.KAMENECKA,M.RANCE,A.I.SHULMAN,D.J.MANGELSDORF,P.R.GRIFFIN, AUTHOR 4 K.W.NETTLES REVDAT 2 15-NOV-23 4ZO1 1 REMARK ATOM REVDAT 1 02-SEP-15 4ZO1 0 JRNL AUTH D.J.KOJETIN,E.MATTA-CAMACHO,T.S.HUGHES,S.SRINIVASAN, JRNL AUTH 2 J.C.NWACHUKWU,V.CAVETT,J.NOWAK,M.J.CHALMERS,D.P.MARCIANO, JRNL AUTH 3 T.M.KAMENECKA,A.I.SHULMAN,M.RANCE,P.R.GRIFFIN,J.B.BRUNING, JRNL AUTH 4 K.W.NETTLES JRNL TITL STRUCTURAL MECHANISM FOR SIGNAL TRANSDUCTION IN RXR NUCLEAR JRNL TITL 2 RECEPTOR HETERODIMERS. JRNL REF NAT COMMUN V. 6 8013 2015 JRNL REFN ESSN 2041-1723 JRNL PMID 26289479 JRNL DOI 10.1038/NCOMMS9013 REMARK 2 REMARK 2 RESOLUTION. 3.22 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.6_289 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.22 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 14.93 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 76.3 REMARK 3 NUMBER OF REFLECTIONS : 6844 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.239 REMARK 3 R VALUE (WORKING SET) : 0.236 REMARK 3 FREE R VALUE : 0.281 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.360 REMARK 3 FREE R VALUE TEST SET COUNT : 367 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 14.9247 - 4.6151 0.99 2923 160 0.2064 0.2659 REMARK 3 2 4.6151 - 3.6812 0.99 2751 155 0.2704 0.2853 REMARK 3 3 3.6812 - 3.2212 0.29 803 52 0.3322 0.3540 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.23 REMARK 3 B_SOL : 67.57 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.480 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.030 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 93.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 133.2 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -10.45140 REMARK 3 B22 (A**2) : -10.45140 REMARK 3 B33 (A**2) : -6.28220 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 3313 REMARK 3 ANGLE : 0.648 4523 REMARK 3 CHIRALITY : 0.039 537 REMARK 3 PLANARITY : 0.002 585 REMARK 3 DIHEDRAL : 10.444 1098 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4ZO1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-MAY-15. REMARK 100 THE DEPOSITION ID IS D_1000209602. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-FEB-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9 REMARK 200 MONOCHROMATOR : SIDE SCATTERING BENT CUBE I-BEAM REMARK 200 SINGLE CRYSTAL; ASYMMETRIC CUT REMARK 200 4.965 DEGS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8950 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.200 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.3 REMARK 200 DATA REDUNDANCY : 11.10 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.31 REMARK 200 COMPLETENESS FOR SHELL (%) : 86.8 REMARK 200 DATA REDUNDANCY IN SHELL : 4.90 REMARK 200 R MERGE FOR SHELL (I) : 0.74000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.37 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 3350, 100 MM TRIS PH 8.0, 0.1 REMARK 280 M AMMONIUM ACETATE, AND 1 MM METHOPRENE ACID, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 75.26867 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 150.53733 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 150.53733 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 75.26867 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3540 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19720 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: X, A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO X 254 REMARK 465 ILE X 255 REMARK 465 VAL X 256 REMARK 465 ASN X 257 REMARK 465 ALA X 258 REMARK 465 PRO X 259 REMARK 465 GLU X 260 REMARK 465 GLY X 261 REMARK 465 GLY X 262 REMARK 465 LYS X 263 REMARK 465 LYS A 686 REMARK 465 GLU B 239 REMARK 465 LEU B 240 REMARK 465 ALA B 241 REMARK 465 VAL B 242 REMARK 465 GLU B 243 REMARK 465 PRO B 244 REMARK 465 LYS B 245 REMARK 465 THR B 246 REMARK 465 GLU B 247 REMARK 465 THR B 248 REMARK 465 TYR B 249 REMARK 465 VAL B 250 REMARK 465 GLU B 251 REMARK 465 ALA B 252 REMARK 465 ASN B 253 REMARK 465 MET B 254 REMARK 465 GLY B 255 REMARK 465 LEU B 256 REMARK 465 ASN B 257 REMARK 465 PRO B 258 REMARK 465 SER B 259 REMARK 465 SER B 260 REMARK 465 PRO B 261 REMARK 465 ASN B 262 REMARK 465 ASP B 263 REMARK 465 PRO B 264 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS X 210 CG ND1 CD2 CE1 NE2 REMARK 470 LYS X 211 CG CD CE NZ REMARK 470 ASP X 216 CG OD1 OD2 REMARK 470 GLU X 217 CG CD OE1 OE2 REMARK 470 LEU X 221 CG CD1 CD2 REMARK 470 LYS X 223 CG CD CE NZ REMARK 470 GLU X 227 CG CD OE1 OE2 REMARK 470 GLN X 235 CG CD OE1 NE2 REMARK 470 SER X 237 OG REMARK 470 HIS X 238 CG ND1 CD2 CE1 NE2 REMARK 470 LYS X 240 CG CD CE NZ REMARK 470 GLN X 241 CG CD OE1 NE2 REMARK 470 LYS X 242 CG CD CE NZ REMARK 470 ARG X 243 CG CD NE CZ NH1 NH2 REMARK 470 LYS X 244 CG CD CE NZ REMARK 470 ASP X 249 CG OD1 OD2 REMARK 470 ILE X 250 CG1 CG2 CD1 REMARK 470 GLN X 252 CG CD OE1 NE2 REMARK 470 VAL X 264 CG1 CG2 REMARK 470 ASP X 265 CG OD1 OD2 REMARK 470 LEU X 266 CG CD1 CD2 REMARK 470 GLU X 267 CG CD OE1 OE2 REMARK 470 SER X 270 OG REMARK 470 LYS X 274 CG CD CE NZ REMARK 470 LYS X 289 CG CD CE NZ REMARK 470 CYS X 294 SG REMARK 470 GLU X 299 CG CD OE1 OE2 REMARK 470 SER X 325 OG REMARK 470 GLU X 333 CG CD OE1 OE2 REMARK 470 LYS X 342 CG CD CE NZ REMARK 470 SER X 361 OG REMARK 470 GLU X 390 CG CD OE1 OE2 REMARK 470 ARG X 391 CG CD NE CZ NH1 NH2 REMARK 470 LYS X 394 CG CD CE NZ REMARK 470 SER X 398 OG REMARK 470 LEU X 401 CG CD1 CD2 REMARK 470 LYS X 411 CG CD CE NZ REMARK 470 HIS X 413 CG ND1 CD2 CE1 NE2 REMARK 470 GLU X 445 CG CD OE1 OE2 REMARK 470 THR X 448 OG1 CG2 REMARK 470 GLU X 449 CG CD OE1 OE2 REMARK 470 LEU X 450 CG CD1 CD2 REMARK 470 ASP X 461 CG OD1 OD2 REMARK 470 LYS A 688 CG CD CE NZ REMARK 470 LEU A 690 CG CD1 CD2 REMARK 470 HIS A 691 CG ND1 CD2 CE1 NE2 REMARK 470 VAL B 232 CG1 CG2 REMARK 470 GLU B 233 CG CD OE1 OE2 REMARK 470 ARG B 234 CG CD NE CZ NH1 NH2 REMARK 470 ILE B 235 CG1 CG2 CD1 REMARK 470 GLU B 237 CG CD OE1 OE2 REMARK 470 VAL B 265 CG1 CG2 REMARK 470 THR B 266 OG1 CG2 REMARK 470 ASN B 267 CG OD1 ND2 REMARK 470 ILE B 268 CG1 CG2 CD1 REMARK 470 GLN B 270 CG CD OE1 NE2 REMARK 470 ASP B 273 CG OD1 OD2 REMARK 470 LYS B 274 CG CD CE NZ REMARK 470 GLN B 275 CG CD OE1 NE2 REMARK 470 PHE B 277 CG CD1 CD2 CE1 CE2 CZ REMARK 470 THR B 278 OG1 CG2 REMARK 470 LEU B 279 CG CD1 CD2 REMARK 470 LYS B 284 CG CD CE NZ REMARK 470 ARG B 285 CG CD NE CZ NH1 NH2 REMARK 470 SER B 290 OG REMARK 470 LEU B 294 CG CD1 CD2 REMARK 470 ILE B 318 CG1 CG2 CD1 REMARK 470 LYS B 321 CG CD CE NZ REMARK 470 ILE B 324 CG1 CG2 CD1 REMARK 470 LEU B 325 CG CD1 CD2 REMARK 470 LEU B 326 CG CD1 CD2 REMARK 470 THR B 328 OG1 CG2 REMARK 470 LEU B 330 CG CD1 CD2 REMARK 470 HIS B 333 CG ND1 CD2 CE1 NE2 REMARK 470 SER B 336 OG REMARK 470 MET B 360 CG SD CE REMARK 470 GLN B 361 CG CD OE1 NE2 REMARK 470 LYS B 364 CG CD CE NZ REMARK 470 LYS B 381 CG CD CE NZ REMARK 470 GLU B 388 CG CD OE1 OE2 REMARK 470 LYS B 395 CG CD CE NZ REMARK 470 LYS B 405 CG CD CE NZ REMARK 470 HIS B 406 CG ND1 CD2 CE1 NE2 REMARK 470 LYS B 431 CG CD CE NZ REMARK 470 LEU B 433 CG CD1 CD2 REMARK 470 GLU B 434 CG CD OE1 OE2 REMARK 470 LEU B 436 CG CD1 CD2 REMARK 470 PHE B 437 CG CD1 CD2 CE1 CE2 CZ REMARK 470 PHE B 438 CG CD1 CD2 CE1 CE2 CZ REMARK 470 PHE B 439 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS B 440 CG CD CE NZ REMARK 470 LEU B 441 CG CD1 CD2 REMARK 470 ILE B 442 CG1 CG2 CD1 REMARK 470 ASP B 444 CG OD1 OD2 REMARK 470 THR B 445 OG1 CG2 REMARK 470 ILE B 447 CG1 CG2 CD1 REMARK 470 ASP B 448 CG OD1 OD2 REMARK 470 THR B 449 OG1 CG2 REMARK 470 MET B 452 CG SD CE REMARK 470 GLU B 453 CG CD OE1 OE2 REMARK 470 MET B 454 CG SD CE REMARK 470 LEU B 455 CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN X 235 -0.51 66.30 REMARK 500 ASP X 265 109.41 -47.34 REMARK 500 ARG X 320 43.74 -108.64 REMARK 500 ASN X 331 18.81 55.54 REMARK 500 GLU X 333 -18.53 -149.14 REMARK 500 ALA X 387 -63.83 -105.10 REMARK 500 GLU X 445 -72.38 -88.32 REMARK 500 LYS A 688 -126.35 -176.00 REMARK 500 ALA B 272 -57.88 70.72 REMARK 500 HIS B 288 -6.78 76.82 REMARK 500 TRP B 305 -38.05 -37.27 REMARK 500 SER B 312 -74.25 -62.94 REMARK 500 THR B 328 22.39 -74.18 REMARK 500 LEU B 330 90.96 -62.83 REMARK 500 LEU B 353 -78.17 -118.91 REMARK 500 LEU B 420 0.04 -68.77 REMARK 500 PHE B 437 -128.42 -136.14 REMARK 500 PHE B 438 -71.67 64.82 REMARK 500 ASP B 448 -31.94 -162.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue T3 X 500 DBREF 4ZO1 X 210 461 UNP P10828 THB_HUMAN 210 461 DBREF 4ZO1 A 686 694 PDB 4ZO1 4ZO1 686 694 DBREF 4ZO1 B 231 455 UNP P19793 RXRA_HUMAN 231 455 SEQRES 1 X 252 HIS LYS PRO GLU PRO THR ASP GLU GLU TRP GLU LEU ILE SEQRES 2 X 252 LYS THR VAL THR GLU ALA HIS VAL ALA THR ASN ALA GLN SEQRES 3 X 252 GLY SER HIS TRP LYS GLN LYS ARG LYS PHE LEU PRO GLU SEQRES 4 X 252 ASP ILE GLY GLN ALA PRO ILE VAL ASN ALA PRO GLU GLY SEQRES 5 X 252 GLY LYS VAL ASP LEU GLU ALA PHE SER HIS PHE THR LYS SEQRES 6 X 252 ILE ILE THR PRO ALA ILE THR ARG VAL VAL ASP PHE ALA SEQRES 7 X 252 LYS LYS LEU PRO MET PHE CYS GLU LEU PRO CYS GLU ASP SEQRES 8 X 252 GLN ILE ILE LEU LEU LYS GLY CYS CYS MET GLU ILE MET SEQRES 9 X 252 SER LEU ARG ALA ALA VAL ARG TYR ASP PRO GLU SER GLU SEQRES 10 X 252 THR LEU THR LEU ASN GLY GLU MET ALA VAL THR ARG GLY SEQRES 11 X 252 GLN LEU LYS ASN GLY GLY LEU GLY VAL VAL SER ASP ALA SEQRES 12 X 252 ILE PHE ASP LEU GLY MET SER LEU SER SER PHE ASN LEU SEQRES 13 X 252 ASP ASP THR GLU VAL ALA LEU LEU GLN ALA VAL LEU LEU SEQRES 14 X 252 MET SER SER ASP ARG PRO GLY LEU ALA CYS VAL GLU ARG SEQRES 15 X 252 ILE GLU LYS TYR GLN ASP SER PHE LEU LEU ALA PHE GLU SEQRES 16 X 252 HIS TYR ILE ASN TYR ARG LYS HIS HIS VAL THR HIS PHE SEQRES 17 X 252 TRP PRO LYS LEU LEU MET LYS VAL THR ASP LEU ARG MET SEQRES 18 X 252 ILE GLY ALA CYS HIS ALA SER ARG PHE LEU HIS MET LYS SEQRES 19 X 252 VAL GLU CYS PRO THR GLU LEU PHE PRO PRO LEU PHE LEU SEQRES 20 X 252 GLU VAL PHE GLU ASP SEQRES 1 A 9 LYS HIS LYS ILE LEU HIS ARG LEU LEU SEQRES 1 B 225 PRO VAL GLU ARG ILE LEU GLU ALA GLU LEU ALA VAL GLU SEQRES 2 B 225 PRO LYS THR GLU THR TYR VAL GLU ALA ASN MET GLY LEU SEQRES 3 B 225 ASN PRO SER SER PRO ASN ASP PRO VAL THR ASN ILE CYS SEQRES 4 B 225 GLN ALA ALA ASP LYS GLN LEU PHE THR LEU VAL GLU TRP SEQRES 5 B 225 ALA LYS ARG ILE PRO HIS PHE SER GLU LEU PRO LEU ASP SEQRES 6 B 225 ASP GLN VAL ILE LEU LEU ARG ALA GLY TRP ASN GLU LEU SEQRES 7 B 225 LEU ILE ALA SER PHE SER HIS ARG SER ILE ALA VAL LYS SEQRES 8 B 225 ASP GLY ILE LEU LEU ALA THR GLY LEU HIS VAL HIS ARG SEQRES 9 B 225 ASN SER ALA HIS SER ALA GLY VAL GLY ALA ILE PHE ASP SEQRES 10 B 225 ARG VAL LEU THR GLU LEU VAL SER LYS MET ARG ASP MET SEQRES 11 B 225 GLN MET ASP LYS THR GLU LEU GLY CYS LEU ARG ALA ILE SEQRES 12 B 225 VAL LEU PHE ASN PRO ASP SER LYS GLY LEU SER ASN PRO SEQRES 13 B 225 ALA GLU VAL GLU ALA LEU ARG GLU LYS VAL TYR ALA SER SEQRES 14 B 225 LEU GLU ALA TYR CYS LYS HIS LYS TYR PRO GLU GLN PRO SEQRES 15 B 225 GLY ARG PHE ALA LYS LEU LEU LEU ARG LEU PRO ALA LEU SEQRES 16 B 225 ARG SER ILE GLY LEU LYS CYS LEU GLU HIS LEU PHE PHE SEQRES 17 B 225 PHE LYS LEU ILE GLY ASP THR PRO ILE ASP THR PHE LEU SEQRES 18 B 225 MET GLU MET LEU HET T3 X 500 23 HETNAM T3 3,5,3'TRIIODOTHYRONINE HETSYN T3 T3; THYROID HORMONE; LIOTHYRONINE FORMUL 4 T3 C15 H12 I3 N O4 HELIX 1 AA1 THR X 215 ALA X 231 1 17 HELIX 2 AA2 ASP X 265 LYS X 274 1 10 HELIX 3 AA3 ILE X 275 LYS X 289 1 15 HELIX 4 AA4 LEU X 290 GLU X 295 1 6 HELIX 5 AA5 PRO X 297 VAL X 319 1 23 HELIX 6 AA6 ARG X 338 GLY X 344 1 7 HELIX 7 AA7 GLY X 347 ASN X 364 1 18 HELIX 8 AA8 ASP X 366 MET X 379 1 14 HELIX 9 AA9 CYS X 388 LYS X 411 1 24 HELIX 10 AB1 HIS X 416 CYS X 446 1 31 HELIX 11 AB2 PRO X 452 GLU X 460 1 9 HELIX 12 AB3 LYS A 688 LEU A 693 1 6 HELIX 13 AB4 VAL B 232 GLU B 237 1 6 HELIX 14 AB5 LYS B 274 ARG B 285 1 12 HELIX 15 AB6 HIS B 288 LEU B 292 5 5 HELIX 16 AB7 PRO B 293 SER B 317 1 25 HELIX 17 AB8 ILE B 318 VAL B 320 5 3 HELIX 18 AB9 ARG B 334 ALA B 340 1 7 HELIX 19 AC1 VAL B 342 LEU B 353 1 12 HELIX 20 AC2 LEU B 353 MET B 360 1 8 HELIX 21 AC3 ASP B 363 PHE B 376 1 14 HELIX 22 AC4 ASN B 385 TYR B 408 1 24 HELIX 23 AC5 GLY B 413 LEU B 420 1 8 HELIX 24 AC6 LEU B 420 LEU B 436 1 17 HELIX 25 AC7 PHE B 439 GLY B 443 5 5 HELIX 26 AC8 ASP B 448 LEU B 455 1 8 SHEET 1 AA1 3 LYS X 244 PHE X 245 0 SHEET 2 AA1 3 MET X 334 THR X 337 1 O ALA X 335 N LYS X 244 SHEET 3 AA1 3 THR X 327 LEU X 330 -1 N LEU X 330 O MET X 334 SHEET 1 AA2 2 GLY B 323 ILE B 324 0 SHEET 2 AA2 2 VAL B 332 HIS B 333 -1 O VAL B 332 N ILE B 324 SSBOND 1 CYS B 269 CYS B 269 1555 6555 2.03 SITE 1 AC1 12 PHE X 272 ILE X 276 ALA X 279 ARG X 282 SITE 2 AC1 12 ARG X 316 ARG X 320 THR X 329 LEU X 330 SITE 3 AC1 12 ASN X 331 GLY X 344 HIS X 435 PHE X 455 CRYST1 63.252 63.252 225.806 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015810 0.009128 0.000000 0.00000 SCALE2 0.000000 0.018256 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004429 0.00000